Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.67 |
| ▸ | CA2 | P00918 | 15/20 | 0.67 |
| ▸ | CA9 | Q16790 | 13/20 | 0.67 |
| ▸ | CA12 | O43570 | 4/20 | 0.67 |
| ▸ | CA7 | P43166 | 4/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.67 |
| ▸ | CA3 | P07451 | 3/20 | 0.67 |
| ▸ | CA4 | P22748 | 3/20 | 0.67 |
| ▸ | CA6 | P23280 | 3/20 | 0.67 |
| ▸ | CA5A | P35218 | 3/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL364864 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL9097777 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL771782 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL456239 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5718521 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL10725960 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5710133 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL185576 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336074 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL44522 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3284807-A1 | PEARLESCENT CONCENTRATE AND METHOD FOR PRODUCING THE SAME | Clariant International Ltd (CH) | 2018-02-21 | — | — | EP | disclosed |
| CN-107207996-A | Cleasing compositions and forming method thereof | 巴斯夫欧洲公司 | 2017-09-26 | — | — | CN | disclosed |
| EP-2298711-B1 | Compound and method for producing sand-lime brick | SIKA TECH AG (CH) | 2017-03-15 | — | — | EP | disclosed |
| US-8623809-B2 | Pearlescent concentrate and process for production | OTC GMBH (DE) | 2014-01-07 | — | — | US | disclosed |
| EP-2480516-A1 | COMPOSITION AND METHOD FOR PRODUCING LIME SAND BRICK | Sika Technology AG (CH) | 2012-08-01 | — | — | EP | disclosed |
| EP-2470630-A2 | PEARLESCENT CONCENTRATE AND METHOD FOR PRODUCING THE SAME | OTC GmbH (DE) | 2012-07-04 | — | — | EP | disclosed |
| US-20120149629-A1 | PEARLESCENT CONCENTRATE AND PROCESS FOR PRODUCTION | OTC GMBH (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20110224170-A1 | Pyranopyranone derivatives as antimicrobial agents | BASF SE (DE) | 2011-09-15 | — | — | US | disclosed |
| WO-2011107411-A1 | PYRANOPYRANONE DERIVATIVES AS ANTIMICROBIAL AGENTS | BASF SE (DE) | 2011-09-09 | — | — | WO | disclosed |
| WO-2011048011-A2 | BENZOTROPOLONE DERIVATIVES AS ANTIMICROBIAL AGENTS | BASF SE (DE) | 2011-04-28 | — | — | WO | disclosed |
| WO-2011033125-A1 | COMPOSITION AND METHOD FOR PRODUCING LIME SAND BRICK | SIKA TECHNOLOGY AG (CH) | 2011-03-24 | — | — | WO | disclosed |
| EP-2298711-A1 | Compound and method for producing sand-lime brick | Sika Technology AG (CH) | 2011-03-23 | — | — | EP | disclosed |
| WO-2011023803-A2 | PEARLESCENT CONCENTRATE AND METHOD FOR PRODUCING THE SAME | OTC GMBH (DE) | 2011-03-03 | — | — | WO | disclosed |
| CN-100393705-C | Developer component and use thereof for dyeing keratin fibres | HENKEL KGAA (DE) | 2008-06-11 | — | — | CN | disclosed |
| CN-1578771-A | Developer components and their use for dyeing keratinic fibers | HENKEL KGAA (DE) | 2005-02-09 | — | — | CN | disclosed |
| EP-0252277-A2 | Aqueous preparations of sodium lauryl- and -myristyl sulfate with low cloud point | Henkel Kommanditgesellschaft auf Aktien (DE) | 1988-01-13 | — | — | EP | disclosed |
| US-4391606-A | Azo polyether dyestuffs, formulations of these dyestuffs, their preparation and their use | BAYER AKTIENGESELLSCHAFT (DE) | 1983-07-05 | — | — | US | disclosed |
| US-4272511-A | POLYMER OF VINYLPYRROLIDONE, VINYL ACETATE, CROTONIC ACID AND AT LEAST ONE OTHER MONOMER | L'OREAL (FR) | 1981-06-09 | — | — | US | disclosed |
| US-4249902-A | DYEING LIQUID COMPRISING ORGANOPHILIC DYE WITH MELTING POINTS BELOW 140 HOMOGENEOUSLY MIXED WITH POLAR/NONPOLAR EMULSIFIER | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-10 | — | — | US | disclosed |
| US-4150151-A | ETHANOL, OIL OF SPEARMINT OR PEPPERMINT, METAL OR AMMONIUM ALKUL SULFATE | LEVER BROTHERS COMPANY (US) | 1979-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224170-A1 | Pyranopyranone derivatives as antimicrobial agents | NR1H2, CBR3, NR1H3 | CA1 3872/4885CA2 3539/4885CA9 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.